No Picture
Business News

J&J blockbuster loses ground to biosimilars despite Quebec court ruling

Johnson & Johnson’s Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec’s public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows.

…read more […]

No Picture
Business News

Trade talks between U.S. and China ‘hit a snag’ over farm purchases: WSJ

U.S.-China trade negotiations have ‘hit a snag’ over farm purchases, with China not wanting a deal that looks one-sided in the favor of the United States, the Wall Street Journal reported https://on.wsj.com/2CEYDR7 on Wednesday, citing people familiar with the matter.

…read more […]